Abstract
The use of intrathecal agents to treat pain and other diseases, such as spasticity, is based on the principle that delivering drugs directly to the cerebral spinal fluid (CSF) bypasses the first-pass effect and results in increased potency and reduced systemic side-effects as compared to other routes of delivery such as the oral or transdermal approach. This may improve efficacy and sustainability, as compared to epidural, intravenous, oral, or transdermal preparations.
Original language | English (US) |
---|---|
Title of host publication | Atlas of Implantable Therapies for Pain Management |
Subtitle of host publication | Second Edition |
Publisher | Springer New York |
Pages | 287-291 |
Number of pages | 5 |
ISBN (Electronic) | 9781493921102 |
ISBN (Print) | 9781493921096 |
DOIs | |
State | Published - Jan 1 2015 |
Keywords
- Guidelines
- Intrathecal drug delivery
- Intrathecal medication
- Selection
- Targeted drug delivery
ASJC Scopus subject areas
- General Medicine